Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Use of Porous Implants for the Prosthetic Rehabilitation of Fibula Free Flap Reconstructed Patients

Brauner, Edoardo, DDS, PhD; Di Carlo, Stefano, MD, DDS; Ciolfi, Alessandro, DDS; Pompa, Giorgio, MD, DDS; Jamshir, Sara, DDS; De Angelis, Francesca, DDS, PhD; Della Monaca, Marco, MD; Valentini, Valentino, MD, DDS

Journal of Craniofacial Surgery: June 2019 - Volume 30 - Issue 4 - p 1163–1169
doi: 10.1097/SCS.0000000000005218
Clinical Studies

Vascularized free flaps represent today the gold standard in Maxillo-Facial reconstructive treatment of the upper and lower compromised maxillas.

The aim of this study is to perform the advantages and disadvantages of the vascularized fibula free flap and the available rehabilitation options with porous implants.

In this study the authors analyzed 45 patients with 211 inserted implants treated and reconstructed with vascularized fibula flaps. The authors compared the use of 103 titanium tapered implants (with micro rough surface) versus 108 tantalum-titanium porous implants to evaluate the bone reabsorption and implant survival. Immediate implant stability, the peri-implant reabsorption, and the survival were evaluated. The follow-up was after 3, 6, 12, and 24 months.

The authors found that for the 108 Zimmer TM they had an average bone loss of 1 mm ± 0.2 mm after 1 year of follow-up, compared with the other implants where the average bone loss was 2.27 mm ± 0.4.

This study demonstrated that the problems caused by different fibula flaps level, compared with the mandibula or, with adjacent teeth in the maxilla, can be solved using TM porous implants that almost duplicate the fixture surface and guarantees long life prognosis to the authors’ prosthetic devices.

Department of Oral and Maxillofacial Sciences, Sapienza University of Rome, Rome, Italy.

Address correspondence and reprint requests to Stefano Di Carlo, MD, DDS, Universita degli Studi di Roma La Sapienza Facolta di Medicina e Odontoiatria, Via Caserta 6, Rome, Italy 00161; E-mail:

Received 5 March, 2018

Accepted 11 November, 2018

The authors report no conflicts of interest.

© 2019 by Mutaz B. Habal, MD.